1 – 10 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Time between milestone events in the Alzheimer's disease amyloid cascade
Insel, Philip S. LU ; Donohue, Michael C. ; Berron, David LU ; Hansson, Oskar LU
and Mattsson-Carlgren, Niklas
LU
(2021)
In NeuroImage
227.
Mark
- 2020
- An Epigenetic Approach to Semantic Categories
-
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
Ossenkoppele, Rik LU ; Lyoo, Chul Hyoung ; Sudre, Carole H. ; van Westen, Danielle LU
; Cho, Hanna
; Ryu, Young Hoon
; Choi, Jae Yong
; Smith, Ruben
LU
; Strandberg, Olof
LU
and Palmqvist, Sebastian
LU
, et al.
(2020)
In Alzheimer's and Dementia
16(2).
p.335-344
Mark
-
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Svenningsson, Per ; Odin, Per LU ; Dizdar, Nil ; Johansson, Anders ; Grigoriou, Sotirios LU
; Tsitsi, Panagiota
; Wictorin, Klas
LU
; Bergquist, Filip
; Nyholm, Dag
LU
and Rinne, Juha
, et al.
(2020)
In Movement Disorders
35(6).
p.1046-1054
Mark
- Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism
- Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
- Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease
- Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
- The type and timing of patent ductus arteriosus treatment was associated with neurodevelopment when extremely preterm infants reached 6.5 years
- Tau PET and relative cerebral blood flow in dementia with Lewy bodies : A PET study